Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors: Benefits in Diabetics With Cardiovascular Disease

Optimal blood glucose control helps reduce the development of the complications of type II diabetes mellitus (T2DM). T2DM patients usually are at increased risk of cardiovascular (CV) events and mortality. Therapies and strategies to treat diabetes and its related CV outcomes still need more investi...

Descripción completa

Detalles Bibliográficos
Autores principales: Aftab, Saba, Vetrivel Suresh, Rishwanth, Sherali, Nazleen, Daniyal, Muhammad, Tsouklidis, Nicholas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535950/
https://www.ncbi.nlm.nih.gov/pubmed/33042651
http://dx.doi.org/10.7759/cureus.10783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535950/
https://www.ncbi.nlm.nih.gov/pubmed/33042651
http://dx.doi.org/10.7759/cureus.10783

Ejemplares similares